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Background: There is still uncertainty about the optimal strategy in patients with multivessel disease undergoing primary PCI for cardiogenic 
shock. Therefore we compared outcome of patients with culprit lesion only PCI and immediate multivessel PCI for cardiogenic shock in a prospective 
study.
methods: We used the data of the prospective IABP-Shock II trial and included patients with primary PCI for cardiogenic shock with 2-3 vessel 
disease. We excluded patients with left main PCI and patients with prior coronary artery bypass surgery. Treatment with multivessel PCI or culprit 
lesion only PCI was left on the discretion of the operator.
results: Between 2009 and 2011 a total of 450 patients 2-3 vessel disease were treated with primary PCI for cardiogenic shock. Of these 167 (37 
%) received immediate multivessel PCI while in the remaining only the culprit vessel was treated.
Baseline characteristics, procedural features and outcomes are given in the table. 
Culprit lesion PCI
(n=283
Multivessel PCI
(n=167)
p-value
Age (years) 70.0 70.0 0.4
Diabetes 32 % 40 % 0.1
Renal insuffiency 24 % 20 % 0.2
STEMI 77 % 70 % 0.5
3-vessel disease 62 % 72 % 0.04
TIMI 3 after PCI 80 % 83 % 0.3
IABP 51 % 52 % 0,3
30-d reinfarction 2.3 % 1.0 % 0.5
30-d mortality 43.8 % 47.3 % 0.5
conclusion: Immediate multivessel PCI for cardiogenic shock used in about 40 % of patients is associated with similar success rates as culprit 
lesion PCI, but with a slightly higher mortality. Therefore a randomized trial seems warranted to evaluate the optimal interventional strategy in these 
patients.
